Thyrocare Technologies Limited

Thyrocare Technologies Limited

Thyrocare Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

Thyrocare Technologies Limited

Thyrocare Technologies Limited has informed the Exchange regarding Change in Auditors of the company, with M/s. M S K A & Associates LLP being replaced by M/s Price Waterhouse Chartered Accountants LLP as the Statutory Auditors.

Thyrocare Technologies Limited

Thyrocare Technologies Limited held its 26th Annual General Meeting on June 30, 2026, where 66 shareholders representing 61.10% of the total paid-up equity share capital attended. The meeting was conducted in physical mode at the Corporate Office of the Company, and remote e-voting was available from June 26 to June 29, 2026. The Independent Auditors' Reports on the Standalone and Consolidated Financial Statements did not contain any qualifications, reservations, or adverse remarks.

Thyrocare Technologies Limited

Thyrocare Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for trading in Company’s equity shares for Designated Persons and their immediate relatives from July 01, 2026, and would be re-opened 48 hours after the announcement of un-audited financial results for the quarter ended June 30, 2026.